Market Whales and Their Recent Bets on NVO Options
Market Whales and Their Recent Bets on NVO Options
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $75.0 to $155.0 for Novo Nordisk during the past quarter. Deep-pocketed investors have adopted a bullish approach towards Novo Nordisk (NYSE:NVO), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in NVO usually suggests something big is about to happen.
資金雄厚的投資者對諾和諾德（紐交所:NVO）採取了看好的態度，這一點市場參與者不應忽視。我們在Benzinga對公共期權記錄的追蹤今天揭示了這一重大舉動。這些投資者的身份仍然未知，但在NVO上發生如此重大舉動通常意味着一些重要的事情即將發生。
We gleaned this information from our observations today when Benzinga's options scanner highlighted 17 extraordinary options activities for Novo Nordisk. This level of activity is out of the ordinary.
今天我們從觀察中得出了這一信息，當Benzinga的期權掃描儀突出顯示諾和諾德的17項異常期權活動時。這一活動水平並不尋常。
The general mood among these heavyweight investors is divided, with 52% leaning bullish and 35% bearish. Among these notable options, 9 are puts, totaling $352,686, and 8 are calls, amounting to $577,375.
這些重量級投資者的總體情緒是分化的，52%的人看好，35%的人看淡。在這些顯著的期權中，9個是看跌期權，總額爲$352,686，8個是看漲期權，總額爲$577,375。
What's The Price Target?
價格目標是什麼？
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $75.0 to $155.0 for Novo Nordisk during the past quarter.
分析這些合約的成交量和未平倉合約，似乎大玩家在過去一個季度內對諾和諾德的價格區間關注在$75.0到$155.0之間。
Volume & Open Interest Trends
成交量和未平倉量趨勢
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
觀察成交量和未平倉合約是進行股票盡職調查的一個有見地的方法。
This data can help you track the liquidity and interest for Novo Nordisk's options for a given strike price.
這些數據可以幫助您追蹤諾和諾德在特定執行價格下的期權流動性和興趣。
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Novo Nordisk's whale activity within a strike price range from $75.0 to $155.0 in the last 30 days.
在下方，我們可以觀察到在過去30天內，諾和諾德的所有鯨魚活動的看漲和看跌期權的成交量和未平倉合約的演變，該行使價格區間爲75.0美元至155.0美元。
Novo Nordisk Option Volume And Open Interest Over Last 30 Days
Novo Nordisk過去30天的期權成交量和未平倉合約
Noteworthy Options Activity:
值得注意的期權活動：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVO | CALL | TRADE | BULLISH | 12/20/24 | $3.35 | $3.15 | $3.7 | $109.00 | $185.0K | 1.0K | 554 |
| NVO | CALL | SWEEP | BULLISH | 01/17/25 | $5.0 | $4.8 | $5.0 | $110.00 | $96.5K | 3.9K | 253 |
| NVO | CALL | TRADE | NEUTRAL | 01/17/25 | $19.0 | $17.9 | $18.4 | $90.00 | $91.9K | 834 | 50 |
| NVO | PUT | SWEEP | BEARISH | 12/20/24 | $3.2 | $3.0 | $3.2 | $103.00 | $72.9K | 2.1K | 778 |
| NVO | PUT | SWEEP | BEARISH | 01/03/25 | $3.25 | $3.05 | $3.24 | $100.00 | $56.6K | 342 | 211 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 行權價 | 總交易價格 | 未平倉合約 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVO | 看漲 | 交易 | 看好 | 12/20/24 | $3.35 | $3.15 | $3.7 | $109.00 | $185.0K | 1.0K | 554 |
| NVO | 看漲 | 掃單 | 看好 | 01/17/25 | $5.0 | $4.8 | $5.0 | $110.00 | 96.5K美元 | 3.9K | 253 |
| NVO | 看漲 | 交易 | 中立 | 01/17/25 | $19.0 | $17.9 | $18.4 | $90.00 | $91.9K | 834 | 50 |
| NVO | 看跌 | 掃單 | 看淡 | 12/20/24 | $3.2 | $3.0 | $3.2 | $103.00 | 72.9K美元 | 2.1K | 778 |
| NVO | 看跌 | 掃單 | 看淡 | 01/03/25 | $3.25 | $3.05 | $3.24 | $100.00 | 56.6K美元 | 342 | 211 |
About Novo Nordisk
關於諾和諾德
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
諾和諾德在全球品牌糖尿病治療市場中佔據大約三分之一的份額，是世界領先的糖尿病護理產品提供商。該公司總部位於丹麥，生產和銷售多種人用和現代胰島素、可注射的糖尿病治療藥物（如GLP-1療法）、口服抗糖尿病藥物以及肥胖症治療藥物。諾和諾德還有一個生物製藥部門（大約佔營業收入的10%），專門研究血友病和其他疾病的蛋白質療法。
Having examined the options trading patterns of Novo Nordisk, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
在檢查諾和諾德的期權交易模式後，我們的注意力直接轉向該公司。這一轉變使我們能夠深入分析其當前的市場地位和表現。
Novo Nordisk's Current Market Status
諾和諾德的當前市場狀態
- Trading volume stands at 3,835,436, with NVO's price down by -2.67%, positioned at $105.72.
- RSI indicators show the stock to be may be approaching overbought.
- Earnings announcement expected in 47 days.
- 交易量爲3,835,436，NVO的價格下跌了-2.67%，現報$105.72。
- 相對強弱指數（RSI）因子顯示該股票可能接近超買狀態。
- 預計將在47天后公佈業績。
Turn $1000 into $1270 in just 20 days?
在短短20天內將1000美元變成1270美元？
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.
一位擁有20年經驗的期權交易員揭示了他的單行圖表技巧，幫助判斷何時買入和賣出。複製他的交易，這些交易每20天平均獲得27%的利潤。點擊這裏獲取訪問權限。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Novo Nordisk with Benzinga Pro for real-time alerts.
期權交易涉及更大的風險，但也提供了更高利潤的潛力。精明的交易者通過不斷的教育、戰略交易調整、利用各種因子，並保持對市場動態的關注來降低這些風險。通過Benzinga Pro跟蹤Novo Nordisk的最新期權交易，獲取實時提醒。
譯文內容由第三人軟體翻譯。
